Aeon Raises $6 Million in Seed Extension Round
Aeon, a Zurich-based health technology company, has successfully raised $6 million in a seed extension funding round. The round was led by Araya Ventures, with participation from Concentric, GoHub Ventures, Kadmos Capital, Calm/Storm Ventures, N, V Capital, and Bigwave Capital. Aeon specializes in early detection of health risk factors by combining whole-body MRI scans with comprehensive blood analysis to provide precise and reliable insights.
Leadership and Vision
The company is led by CEO and Founder Tim Seithe, alongside CPO and Co-Founder Samuel Frey. Together, they are focused on advancing Aeon's mission to improve early health risk detection through innovative technology.
Use of Funds
While specific plans for the newly raised funds were not disclosed, it can be expected that Aeon will utilize the capital to enhance its technological capabilities, expand its market reach, and possibly increase its workforce to support further growth.
Key Investors
The seed extension round was spearheaded by Araya Ventures, a firm known for its investment in technology-driven companies. Other notable investors include Concentric, GoHub Ventures, Kadmos Capital, Calm/Storm Ventures, N, V Capital, and Bigwave Capital, all of whom bring strategic value and expertise to Aeon's continued development.
Aeon's innovative approach to health risk assessment positions it uniquely within the healthcare technology landscape, offering significant potential for growth and impact.